Christopher T. Lohans

Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials

Tzu‐Lan Yeh, T.M. Leissing, Martine I. Abboud et al. · Chemical Science · 2017 · 226 citations · Full text

Medicine, Biochemistry, Pharmacology +6

The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against Gram-negative bacteria in combination with EDTA treatment

Leah A. Martin‐Visscher, Sabesan Yoganathan, Clarissa S. Sit et al. · FEMS Microbiology Letters · 2011 · 100 citations · Full text

Life Sciences, Biotechnology, Microbiology +13

Structure and Biosynthesis of Carnolysin, a Homologue of Enterococcal Cytolysin with <scp>d</scp>-Amino Acids

Christopher T. Lohans, Jessica L. Li, John C. Vederas · Journal of the American Chemical Society · 2014 · 91 citations · Full text

Life Sciences, Biochemistry, Microbiology +13

Development of Class IIa Bacteriocins as Therapeutic Agents

Christopher T. Lohans, John C. Vederas · International Journal of Microbiology · 2011 · 87 citations · Full text

Pharmacy, Pharmaceutical Biotechnology, Pharmaceutics +16

Genetic Determinants of Reutericyclin Biosynthesis in Lactobacillus reuteri

Xiaoxi B. Lin, Christopher T. Lohans, Rebbeca M. Duar et al. · Applied and Environmental Microbiology · 2015 · 75 citations · Full text

Life Sciences, Genetics, Microbiology +17